Patient perception of dyskinesia in Parkinson's disease
Identifieur interne : 000E79 ( Main/Corpus ); précédent : 000E78; suivant : 000E80Patient perception of dyskinesia in Parkinson's disease
Auteurs : S W Hung ; G M Adeli ; T. Arenovich ; S H Fox ; A E LangSource :
- Journal of Neurology, Neurosurgery & Psychiatry [ 0022-3050 ] ; 2010-10.
Abstract
Objective To evaluate the perception of patients with Parkinson's disease (PD) regarding dyskinesia. Design Multicentre survey. Setting Tertiary referral centres. Patients Patients with PD participated in a survey: those not on dopaminergic medications (group I), those on dopaminergic medications without dyskinesia (group II) and those on dopaminergic medications with dyskinesia (group III). Intervention After a short standardised description and explanation of dyskinesia was provided, patients were asked about the nature and source of prior knowledge of dyskinesia. They were then asked about their perceptions of dyskinesia. Patients in group III were also asked about the duration, the severity of dyskinesia and whether their perception of this problem had changed since its appearance. Main outcome measures Level of concern regarding dyskinesia and whether their perception of dyskinesia would have changed their preference of treatment. Results 259 PD patients completed the survey (group I, 52; group II, 102; group III, 105). Patients with dyskinesia were significantly less concerned about dyskinesia than patients without dyskinesia and were more likely to choose dyskinesia over being parkinsonian. Patients who required fewer changes in medications because of dyskinesia were more likely to choose dyskinesia over parkinsonism. Conclusion Patients with PD experiencing dyskinesia are less likely to be concerned about dyskinesia and more likely to prefer dyskinesia over parkinsonian symptoms than patients without dyskinesia.
Url:
DOI: 10.1136/jnnp.2009.173286
Links to Exploration step
ISTEX:19AEA9BD7C12BC59A32CCB3ACCB75E293016387DLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Patient perception of dyskinesia in Parkinson's disease</title><author><name sortKey="Hung, S W" sort="Hung, S W" uniqKey="Hung S" first="S W" last="Hung">S W Hung</name><affiliation><mods:affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA</mods:affiliation></affiliation></author><author><name sortKey="Adeli, G M" sort="Adeli, G M" uniqKey="Adeli G" first="G M" last="Adeli">G M Adeli</name><affiliation><mods:affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</mods:affiliation></affiliation></author><author><name sortKey="Arenovich, T" sort="Arenovich, T" uniqKey="Arenovich T" first="T" last="Arenovich">T. Arenovich</name><affiliation><mods:affiliation>Clinical Research Department, Centre of Addiction and Mental Health, Toronto, Canada</mods:affiliation></affiliation></author><author><name sortKey="Fox, S H" sort="Fox, S H" uniqKey="Fox S" first="S H" last="Fox">S H Fox</name><affiliation><mods:affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</mods:affiliation></affiliation></author><author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A E" last="Lang">A E Lang</name><affiliation><mods:affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: lang@uhnresearch.ca</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:19AEA9BD7C12BC59A32CCB3ACCB75E293016387D</idno><date when="2010" year="2010">2010</date><idno type="doi">10.1136/jnnp.2009.173286</idno><idno type="url">https://api.istex.fr/document/19AEA9BD7C12BC59A32CCB3ACCB75E293016387D/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000E79</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Patient perception of dyskinesia in Parkinson's disease</title><author><name sortKey="Hung, S W" sort="Hung, S W" uniqKey="Hung S" first="S W" last="Hung">S W Hung</name><affiliation><mods:affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA</mods:affiliation></affiliation></author><author><name sortKey="Adeli, G M" sort="Adeli, G M" uniqKey="Adeli G" first="G M" last="Adeli">G M Adeli</name><affiliation><mods:affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</mods:affiliation></affiliation></author><author><name sortKey="Arenovich, T" sort="Arenovich, T" uniqKey="Arenovich T" first="T" last="Arenovich">T. Arenovich</name><affiliation><mods:affiliation>Clinical Research Department, Centre of Addiction and Mental Health, Toronto, Canada</mods:affiliation></affiliation></author><author><name sortKey="Fox, S H" sort="Fox, S H" uniqKey="Fox S" first="S H" last="Fox">S H Fox</name><affiliation><mods:affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</mods:affiliation></affiliation></author><author><name sortKey="Lang, A E" sort="Lang, A E" uniqKey="Lang A" first="A E" last="Lang">A E Lang</name><affiliation><mods:affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: lang@uhnresearch.ca</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title><title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title><idno type="ISSN">0022-3050</idno><idno type="eISSN">1468-330X</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2010-10">2010-10</date><biblScope unit="volume">81</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1112">1112</biblScope></imprint><idno type="ISSN">0022-3050</idno></series><idno type="istex">19AEA9BD7C12BC59A32CCB3ACCB75E293016387D</idno><idno type="DOI">10.1136/jnnp.2009.173286</idno><idno type="href">jnnp-81-1112.pdf</idno><idno type="ArticleID">jnnp173286</idno><idno type="PMID">20667858</idno><idno type="local">jnnp;81/10/1112</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0022-3050</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Objective To evaluate the perception of patients with Parkinson's disease (PD) regarding dyskinesia. Design Multicentre survey. Setting Tertiary referral centres. Patients Patients with PD participated in a survey: those not on dopaminergic medications (group I), those on dopaminergic medications without dyskinesia (group II) and those on dopaminergic medications with dyskinesia (group III). Intervention After a short standardised description and explanation of dyskinesia was provided, patients were asked about the nature and source of prior knowledge of dyskinesia. They were then asked about their perceptions of dyskinesia. Patients in group III were also asked about the duration, the severity of dyskinesia and whether their perception of this problem had changed since its appearance. Main outcome measures Level of concern regarding dyskinesia and whether their perception of dyskinesia would have changed their preference of treatment. Results 259 PD patients completed the survey (group I, 52; group II, 102; group III, 105). Patients with dyskinesia were significantly less concerned about dyskinesia than patients without dyskinesia and were more likely to choose dyskinesia over being parkinsonian. Patients who required fewer changes in medications because of dyskinesia were more likely to choose dyskinesia over parkinsonism. Conclusion Patients with PD experiencing dyskinesia are less likely to be concerned about dyskinesia and more likely to prefer dyskinesia over parkinsonian symptoms than patients without dyskinesia.</div></front></TEI><istex><corpusName>bmj</corpusName><author><json:item><name>S W Hung</name><affiliations><json:string>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</json:string><json:string>Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA</json:string></affiliations></json:item><json:item><name>G M Adeli</name><affiliations><json:string>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</json:string></affiliations></json:item><json:item><name>T Arenovich</name><affiliations><json:string>Clinical Research Department, Centre of Addiction and Mental Health, Toronto, Canada</json:string></affiliations></json:item><json:item><name>S H Fox</name><affiliations><json:string>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</json:string></affiliations></json:item><json:item><name>A E Lang</name><affiliations><json:string>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</json:string><json:string>E-mail: lang@uhnresearch.ca</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Short report</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dyskinesia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>treatment initiation</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dopamine agonists</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>l-dopa</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>quality of life</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Objective To evaluate the perception of patients with Parkinson's disease (PD) regarding dyskinesia. Design Multicentre survey. Setting Tertiary referral centres. Patients Patients with PD participated in a survey: those not on dopaminergic medications (group I), those on dopaminergic medications without dyskinesia (group II) and those on dopaminergic medications with dyskinesia (group III). Intervention After a short standardised description and explanation of dyskinesia was provided, patients were asked about the nature and source of prior knowledge of dyskinesia. They were then asked about their perceptions of dyskinesia. Patients in group III were also asked about the duration, the severity of dyskinesia and whether their perception of this problem had changed since its appearance. Main outcome measures Level of concern regarding dyskinesia and whether their perception of dyskinesia would have changed their preference of treatment. Results 259 PD patients completed the survey (group I, 52; group II, 102; group III, 105). Patients with dyskinesia were significantly less concerned about dyskinesia than patients without dyskinesia and were more likely to choose dyskinesia over being parkinsonian. Patients who required fewer changes in medications because of dyskinesia were more likely to choose dyskinesia over parkinsonism. Conclusion Patients with PD experiencing dyskinesia are less likely to be concerned about dyskinesia and more likely to prefer dyskinesia over parkinsonian symptoms than patients without dyskinesia.</abstract><qualityIndicators><score>5.756</score><pdfVersion>1.4</pdfVersion><pdfPageSize>595.276 x 793.701 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>7</keywordCount><abstractCharCount>1545</abstractCharCount><pdfWordCount>2652</pdfWordCount><pdfCharCount>18074</pdfCharCount><pdfPageCount>4</pdfPageCount><abstractWordCount>217</abstractWordCount></qualityIndicators><title>Patient perception of dyskinesia in Parkinson's disease</title><pmid><json:string>20667858</json:string></pmid><genre><json:string>brief communication</json:string></genre><host><volume>81</volume><pages><first>1112</first></pages><issn><json:string>0022-3050</json:string></issn><issue>10</issue><genre></genre><language><json:string>unknown</json:string></language><eissn><json:string>1468-330X</json:string></eissn><title>Journal of Neurology, Neurosurgery & Psychiatry</title></host><publicationDate>2010</publicationDate><copyrightDate>2010</copyrightDate><doi><json:string>10.1136/jnnp.2009.173286</json:string></doi><id>19AEA9BD7C12BC59A32CCB3ACCB75E293016387D</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/19AEA9BD7C12BC59A32CCB3ACCB75E293016387D/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/19AEA9BD7C12BC59A32CCB3ACCB75E293016387D/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/19AEA9BD7C12BC59A32CCB3ACCB75E293016387D/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Patient perception of dyskinesia in Parkinson's disease</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>BMJ Publishing Group Ltd</publisher><availability><p>BMJ</p></availability><date>2010-07-28</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Patient perception of dyskinesia in Parkinson's disease</title><author><persName><forename type="first">S W</forename><surname>Hung</surname></persName><affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</affiliation><affiliation>Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA</affiliation></author><author><persName><forename type="first">G M</forename><surname>Adeli</surname></persName><affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</affiliation></author><author><persName><forename type="first">T</forename><surname>Arenovich</surname></persName><affiliation>Clinical Research Department, Centre of Addiction and Mental Health, Toronto, Canada</affiliation></author><author><persName><forename type="first">S H</forename><surname>Fox</surname></persName><affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</affiliation></author><author corresp="yes"><persName><forename type="first">A E</forename><surname>Lang</surname></persName><email>lang@uhnresearch.ca</email><affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</affiliation></author></analytic><monogr><title level="j">Journal of Neurology, Neurosurgery & Psychiatry</title><title level="j" type="abbrev">J Neurol Neurosurg Psychiatry</title><idno type="pISSN">0022-3050</idno><idno type="eISSN">1468-330X</idno><imprint><publisher>BMJ Publishing Group Ltd</publisher><date type="published" when="2010-10"></date><biblScope unit="volume">81</biblScope><biblScope unit="issue">10</biblScope><biblScope unit="page" from="1112">1112</biblScope></imprint></monogr><idno type="istex">19AEA9BD7C12BC59A32CCB3ACCB75E293016387D</idno><idno type="DOI">10.1136/jnnp.2009.173286</idno><idno type="href">jnnp-81-1112.pdf</idno><idno type="ArticleID">jnnp173286</idno><idno type="PMID">20667858</idno><idno type="local">jnnp;81/10/1112</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2010-07-28</date></creation><langUsage><language ident="en">en</language></langUsage><abstract><p>Objective To evaluate the perception of patients with Parkinson's disease (PD) regarding dyskinesia. Design Multicentre survey. Setting Tertiary referral centres. Patients Patients with PD participated in a survey: those not on dopaminergic medications (group I), those on dopaminergic medications without dyskinesia (group II) and those on dopaminergic medications with dyskinesia (group III). Intervention After a short standardised description and explanation of dyskinesia was provided, patients were asked about the nature and source of prior knowledge of dyskinesia. They were then asked about their perceptions of dyskinesia. Patients in group III were also asked about the duration, the severity of dyskinesia and whether their perception of this problem had changed since its appearance. Main outcome measures Level of concern regarding dyskinesia and whether their perception of dyskinesia would have changed their preference of treatment. Results 259 PD patients completed the survey (group I, 52; group II, 102; group III, 105). Patients with dyskinesia were significantly less concerned about dyskinesia than patients without dyskinesia and were more likely to choose dyskinesia over being parkinsonian. Patients who required fewer changes in medications because of dyskinesia were more likely to choose dyskinesia over parkinsonism. Conclusion Patients with PD experiencing dyskinesia are less likely to be concerned about dyskinesia and more likely to prefer dyskinesia over parkinsonian symptoms than patients without dyskinesia.</p></abstract><textClass><keywords scheme="keyword"><list><head>Keywords</head><item><term>Parkinson's disease</term></item><item><term>dyskinesia</term></item><item><term>treatment initiation</term></item><item><term>dopamine agonists</term></item><item><term>l-dopa</term></item><item><term>quality of life</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2010-07-28">Created</change><change when="2010-10">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/19AEA9BD7C12BC59A32CCB3ACCB75E293016387D/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="brief-report"><front><journal-meta><journal-id journal-id-type="hwp">jnnp</journal-id><journal-id journal-id-type="nlm-ta">J Neurol Neurosurg Psychiatry</journal-id><journal-id journal-id-type="publisher-id">jnnp</journal-id><journal-title>Journal of Neurology, Neurosurgery & Psychiatry</journal-title><abbrev-journal-title abbrev-type="publisher">J Neurol Neurosurg Psychiatry</abbrev-journal-title><abbrev-journal-title>J Neurol Neurosurg Psychiatry</abbrev-journal-title><issn pub-type="ppub">0022-3050</issn><issn pub-type="epub">1468-330X</issn><publisher><publisher-name>BMJ Publishing Group Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">jnnp173286</article-id><article-id pub-id-type="doi">10.1136/jnnp.2009.173286</article-id><article-id pub-id-type="other">jnnp;81/10/1112</article-id><article-id pub-id-type="other">jnnp;jnnp.2009.173286</article-id><article-id pub-id-type="pmid">20667858</article-id><article-id pub-id-type="other">1112</article-id><article-id pub-id-type="other">jnnp.2009.173286</article-id><article-categories><subj-group subj-group-type="heading"><subject content-type="original">Short report</subject></subj-group></article-categories><title-group><article-title>Patient perception of dyskinesia in Parkinson's disease</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Hung</surname><given-names>S W</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Adeli</surname><given-names>G M</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Arenovich</surname><given-names>T</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Fox</surname><given-names>S H</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Lang</surname><given-names>A E</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</aff><aff id="aff2"><label>2</label>Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA</aff><aff id="aff3"><label>3</label>Clinical Research Department, Centre of Addiction and Mental Health, Toronto, Canada</aff><author-notes><corresp><label>Correspondence to</label> Dr Anthony E Lang, Movement Disorders Centre, University of Toronto, 399 Bathurst Street, 7 Mc-L, Toronto, Ontario M5T 2S8, Canada; <email>lang@uhnresearch.ca</email></corresp></author-notes><pub-date pub-type="epub-original"><day>28</day><month>7</month><year>2010</year></pub-date><pub-date pub-type="ppub"><month>10</month><year>2010</year></pub-date><pub-date pub-type="epub"><day>28</day><month>7</month><year>2010</year></pub-date><volume>81</volume><volume-id pub-id-type="other">81</volume-id><volume-id pub-id-type="other">81</volume-id><issue>10</issue><issue-id pub-id-type="other">jnnp;81/10</issue-id><issue-id pub-id-type="other">10</issue-id><issue-id pub-id-type="other">81/10</issue-id><fpage>1112</fpage><history><date date-type="received"><day>21</day><month>1</month><year>2009</year></date><date date-type="rev-recd"><day>22</day><month>6</month><year>2009</year></date><date date-type="accepted"><day>24</day><month>6</month><year>2009</year></date></history><permissions><copyright-statement>© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</copyright-statement><copyright-year>2010</copyright-year></permissions><self-uri content-type="pdf" xlink:role="full-text" xlink:href="jnnp-81-1112.pdf"></self-uri><abstract><sec><title>Objective</title><p>To evaluate the perception of patients with Parkinson's disease (PD) regarding dyskinesia.</p></sec><sec><title>Design</title><p>Multicentre survey.</p></sec><sec><title>Setting</title><p>Tertiary referral centres.</p></sec><sec><title>Patients</title><p>Patients with PD participated in a survey: those not on dopaminergic medications (group I), those on dopaminergic medications without dyskinesia (group II) and those on dopaminergic medications with dyskinesia (group III).</p></sec><sec><title>Intervention</title><p>After a short standardised description and explanation of dyskinesia was provided, patients were asked about the nature and source of prior knowledge of dyskinesia. They were then asked about their perceptions of dyskinesia. Patients in group III were also asked about the duration, the severity of dyskinesia and whether their perception of this problem had changed since its appearance.</p></sec><sec><title>Main outcome measures</title><p>Level of concern regarding dyskinesia and whether their perception of dyskinesia would have changed their preference of treatment.</p></sec><sec><title>Results</title><p>259 PD patients completed the survey (group I, 52; group II, 102; group III, 105). Patients with dyskinesia were significantly less concerned about dyskinesia than patients without dyskinesia and were more likely to choose dyskinesia over being parkinsonian. Patients who required fewer changes in medications because of dyskinesia were more likely to choose dyskinesia over parkinsonism.</p></sec><sec><title>Conclusion</title><p>Patients with PD experiencing dyskinesia are less likely to be concerned about dyskinesia and more likely to prefer dyskinesia over parkinsonian symptoms than patients without dyskinesia.</p></sec></abstract><kwd-group><kwd>Parkinson's disease</kwd><kwd>dyskinesia</kwd><kwd>treatment initiation</kwd><kwd>dopamine agonists</kwd><kwd><sc>l</sc>-dopa</kwd><kwd>quality of life</kwd></kwd-group></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Patient perception of dyskinesia in Parkinson's disease</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Patient perception of dyskinesia in Parkinson's disease</title></titleInfo><name type="personal"><namePart type="given">S W</namePart><namePart type="family">Hung</namePart><affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</affiliation><affiliation>Department of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">G M</namePart><namePart type="family">Adeli</namePart><affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T</namePart><namePart type="family">Arenovich</namePart><affiliation>Clinical Research Department, Centre of Addiction and Mental Health, Toronto, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">S H</namePart><namePart type="family">Fox</namePart><affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal" displayLabel="corresp"><namePart type="given">A E</namePart><namePart type="family">Lang</namePart><affiliation>Movement Disorders Centre, Toronto Western Hospital and the Division of Neurology, University of Toronto, Toronto, Canada</affiliation><affiliation>E-mail: lang@uhnresearch.ca</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="brief communication" displayLabel="brief-report"></genre><originInfo><publisher>BMJ Publishing Group Ltd</publisher><dateIssued encoding="w3cdtf">2010-10</dateIssued><dateCreated encoding="w3cdtf">2010-07-28</dateCreated><copyrightDate encoding="w3cdtf">2010</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract>Objective To evaluate the perception of patients with Parkinson's disease (PD) regarding dyskinesia. Design Multicentre survey. Setting Tertiary referral centres. Patients Patients with PD participated in a survey: those not on dopaminergic medications (group I), those on dopaminergic medications without dyskinesia (group II) and those on dopaminergic medications with dyskinesia (group III). Intervention After a short standardised description and explanation of dyskinesia was provided, patients were asked about the nature and source of prior knowledge of dyskinesia. They were then asked about their perceptions of dyskinesia. Patients in group III were also asked about the duration, the severity of dyskinesia and whether their perception of this problem had changed since its appearance. Main outcome measures Level of concern regarding dyskinesia and whether their perception of dyskinesia would have changed their preference of treatment. Results 259 PD patients completed the survey (group I, 52; group II, 102; group III, 105). Patients with dyskinesia were significantly less concerned about dyskinesia than patients without dyskinesia and were more likely to choose dyskinesia over being parkinsonian. Patients who required fewer changes in medications because of dyskinesia were more likely to choose dyskinesia over parkinsonism. Conclusion Patients with PD experiencing dyskinesia are less likely to be concerned about dyskinesia and more likely to prefer dyskinesia over parkinsonian symptoms than patients without dyskinesia.</abstract><subject><genre>Keywords</genre><topic>Parkinson's disease</topic><topic>dyskinesia</topic><topic>treatment initiation</topic><topic>dopamine agonists</topic><topic>l-dopa</topic><topic>quality of life</topic></subject><relatedItem type="host"><titleInfo><title>Journal of Neurology, Neurosurgery & Psychiatry</title></titleInfo><titleInfo type="abbreviated"><title>J Neurol Neurosurg Psychiatry</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0022-3050</identifier><identifier type="eISSN">1468-330X</identifier><identifier type="PublisherID">jnnp</identifier><identifier type="PublisherID-hwp">jnnp</identifier><identifier type="PublisherID-nlm-ta">J Neurol Neurosurg Psychiatry</identifier><part><date>2010</date><detail type="volume"><caption>vol.</caption><number>81</number></detail><detail type="issue"><caption>no.</caption><number>10</number></detail><extent unit="pages"><start>1112</start></extent></part></relatedItem><identifier type="istex">19AEA9BD7C12BC59A32CCB3ACCB75E293016387D</identifier><identifier type="DOI">10.1136/jnnp.2009.173286</identifier><identifier type="href">jnnp-81-1112.pdf</identifier><identifier type="ArticleID">jnnp173286</identifier><identifier type="PMID">20667858</identifier><identifier type="local">jnnp;81/10/1112</identifier><accessCondition type="use and reproduction" contentType="copyright">© 2010, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.</accessCondition><recordInfo><recordContentSource>BMJ</recordContentSource></recordInfo></mods></metadata><annexes><json:item><original>true</original><mimetype>image/jpeg</mimetype><extension>jpeg</extension><uri>https://api.istex.fr/document/19AEA9BD7C12BC59A32CCB3ACCB75E293016387D/annexes/jpeg</uri></json:item></annexes><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E79 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000E79 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:19AEA9BD7C12BC59A32CCB3ACCB75E293016387D
|texte= Patient perception of dyskinesia in Parkinson's disease
}}
| This area was generated with Dilib version V0.6.23. |  |